7Baggers
Quarterly
Annual
    Unit: USD2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 
      
    		                                                             
      operating activities:
    		                                                             
      net income
    		479,936,000 291,317,000 215,752,000 19,073,000 178,084,000 470,130,000 232,268,000 67,652,000 40,237,000 30,626,000 16,181,000 1,270,000 24,844,000 32,479,000 10,822,000 -3,076,000 33,958,000 -5,088,000 -5,525,000 -11,842,000 14,290,000 -1,950,000 -572,000   -377,000 -762,000 -8,931,000 3,991,000 7,113,000 -5,767,000 -6,908,000 -1,512,000 1,139,000 -4,361,000 -1,755,000 12,367,000 8,740,000 -676,000 -3,122,000 51,000 958,000 -1,113,000 -3,660,000 11,448,000 -426,000 -5,861,000 -2,467,000 -2,517,000 20,107,000 14,940,000 -1,712,000 4,817,000         
      adjustments to reconcile net income to net cash from operating activities:
    		                                                             
      depreciation, amortization and other
    		16,782,000 14,401,000 12,792,000 14,486,000 12,705,000 12,308,000 12,415,000 11,886,000 12,480,000 15,051,000 12,282,000 12,487,000 11,971,000 11,943,000 10,704,000 11,544,000 12,075,000 12,949,000 6,236,000 5,887,000 5,690,000 5,199,000 5,187,000 6,287,000 6,123,000 5,849,000 5,717,000 5,618,000 6,202,000 7,787,000 6,885,000 6,361,000 7,332,000 6,237,000 6,334,000 5,067,000 7,056,000 6,776,000 5,623,000 5,282,000 5,580,000 5,746,000 5,298,000 3,386,000 3,379,000 3,547,000 3,324,000 3,246,000 2,209,000 1,888,000 1,612,000           
      stock-based compensation expense
    		7,432,000 6,727,000 7,005,000 5,846,000 5,828,000 6,458,000 5,553,000 5,130,000 3,878,000 3,168,000 3,124,000 3,372,000 3,588,000 2,519,000 2,775,000 3,479,000 2,936,000 3,123,000 1,879,000 2,138,000 1,921,000 2,166,000 1,734,000 2,106,000 1,980,000 1,706,000 1,719,000 1,926,000 2,068,000 1,952,000 1,293,000 1,242,000 2,237,000 3,324,000 1,419,000 1,887,000 2,141,000 1,597,000 1,406,000 1,732,000 1,863,000 2,347,000 1,468,000 1,914,000 1,771,000 1,277,000 1,256,000 1,415,000 1,210,000 2,020,000 787,000 1,162,000 1,259,000 3,395,465 968 934 633     
      amortization of deferred financing costs
    		101,000                                                             
      accretion of interest on deferred consideration
    		982,000 970,000 957,000 1,107,000 1,451,000 1,543,000 1,414,000 1,717,000 1,895,000 1,872,000 1,848,000 2,161,000 2,343,000 2,314,000 2,285,000 2,608,000 2,793,000                                             
      net change in operating lease right-of-use assets and liabilities
    		9,351,000 370,000 861,000 987,000 794,000                                                         
      change in deferred tax assets and liabilities
    		-89,000 23,905,000 157,000 165,000 446,000 -19,770,000 -420,000 -99,000 78,000         264,000 348,000   4,772,000 -157,000 -4,589,000 -2,629,000 2,341,000 -3,937,000 -3,716,000 1,285,000 6,497,000 -5,682,000   -5,378,000 87,000 2,426,000 937,000 3,861,000 -713,000 -1,680,000 1,000 -1,310,000 -1,006,000 -2,352,000 5,885,000                 
      changes in assets and liabilities:
    		                                                             
      accounts receivable
    		-191,452,000 -42,683,000 -289,559,000 24,042,000 427,052,000 -143,878,000 -241,766,000 -8,713,000 -7,737,000 -16,715,000 -33,341,000 24,679,000 -10,682,000 7,979,000 -22,085,000 47,547,000 -25,205,000 -25,470,000 -21,738,000 1,108,000 4,048,000 1,199,000 -9,958,000 10,213,000 -7,719,000 12,619,000 -15,325,000 2,984,000 15,782,000 -10,011,000 -7,224,000 -564,000 13,252,000 -10,289,000 -6,013,000 751,000 18,462,000 -15,438,000 -4,351,000 1,666,000 199,000 2,659,000 -6,435,000 5,340,000 -2,733,000 -615,000 -2,627,000 2,768,000 3,553,000 15,711,000 -16,620,000 3,237,000 6,660,000  -9,136 7,330 2,322     
      inventories
    		17,355,000 -1,706,000 21,463,000 -43,662,000 -61,134,000 -17,954,000 -2,448,000 -33,899,000 -602,000 3,748,000 2,691,000 2,022,000 682,000 -4,129,000 -3,555,000 -1,761,000 5,471,000 -2,389,000 -465,000 -360,000 3,576,000 -2,685,000 -274,000 1,682,000 2,136,000 -1,823,000 -886,000 286,000 786,000 -1,253,000 1,000 1,459,000 2,655,000 -275,000 -2,572,000 -3,902,000 -5,226,000 1,065,000 319,000 -907,000 -1,552,000 197,000 385,000 -402,000 2,873,000 1,556,000 655,000 602,000 -393,000 -2,155,000 -994,000  678,000    431     
      prepaid expenses and other current and non-current assets
    		-7,291,000 1,972,000 4,699,000 -6,116,000 -13,811,000 -9,184,000 -1,289,000 -4,112,000 321,000 -628,000 2,803,000 -1,856,000 3,995,000 845,000 -2,001,000 -6,586,000 -4,939,000 -8,446,000 1,241,000 -368,000 -1,540,000 495,000 -132,000 271,000 -1,186,000 -734,000 60,000 92,000 -457,000 1,152,000 -1,021,000 2,095,000 -1,439,000 3,588,000 -3,943,000 1,995,000 -504,000    -1,731,000                     
      accounts payable
    		52,592,000 13,907,000 6,663,000 -6,264,000 -3,860,000 32,665,000 10,147,000 2,775,000 6,639,000 -1,995,000 5,237,000 -2,610,000 1,802,000 -964,000 5,703,000 -4,475,000 -595,000 10,828,000 6,192,000 253,000 -4,317,000 3,339,000 2,926,000 -3,092,000 1,150,000 -1,135,000 1,780,000 -531,000 -3,196,000 5,160,000 585,000 -769,000 -596,000 191,000 1,117,000 648,000 -2,607,000 2,422,000 -310,000 -1,799,000 1,232,000 415,000 952,000 -1,262,000 21,000 -141,000 -993,000 1,043,000 -2,504,000 53,000 2,574,000           
      accrued payroll and related expenses
    		-10,944,000 8,874,000 12,221,000 -70,000 -16,054,000 5,946,000 5,104,000 7,834,000 -2,860,000 4,743,000 -1,743,000 2,932,000 -6,969,000 1,698,000 1,481,000 4,483,000 -5,988,000 6,148,000 345,000 2,130,000 -1,493,000 1,492,000 -341,000 1,764,000 -3,290,000 289,000 1,403,000 239,000 -870,000 841,000 1,219,000 -254,000 -559,000 419,000 1,621,000 -668,000 -317,000 1,243,000 909,000 180,000 -1,249,000 -1,436,000 1,118,000 -92,000 1,727,000 -947,000 -320,000 -737,000 -632,000 472,000 1,275,000           
      income taxes payable
    		138,384,000 1,015,000 58,307,000 -167,396,000 41,386,000 85,894,000             40,000 -1,761,000 1,799,000 60,000 -10,000 165,000 -167,000 -793,000 940,000 -209,000 -2,000 -1,155,000 -63,000                               
      other current and non-current liabilities
    		-12,167,000 2,092,000 25,640,000 -12,267,000 12,469,000 13,826,000 -12,903,000 6,678,000 6,634,000 8,203,000 2,888,000 -5,846,000 721,000 1,223,000 4,110,000 -2,913,000 2,323,000 2,891,000 2,793,000 -953,000 2,173,000 557,000 -304,000 -2,244,000 7,000 -2,312,000 1,953,000 -6,683,000 5,956,000 -736,000 4,289,000 -2,996,000 745,000 3,683,000 -1,397,000 -2,936,000 509,000 3,647,000 1,662,000 -850,000 -1,656,000 -593,000 958,000 21,000 -458,000 -780,000 512,000 -1,328,000 -3,040,000 -1,251,000 7,642,000           
      net cash from operating activities:
    		500,972,000  77,059,000 -178,024,000 585,457,000  70,455,000 58,997,000 61,180,000  13,330,000 40,534,000 32,897,000  6,666,000 50,648,000 35,814,000  -7,523,000 -5,568,000 29,575,000  -2,350,000                                       
      investing activities:
    		                                                             
      acquisitions of property, equipment, investments and intangibles
    		-22,402,000 -32,325,000                                                            
      proceeds from government assistance allocated to fixed assets
    		 0 13,618,000 9,541,000 13,722,000                                                         
      purchases of marketable securities
    		-15,937,000                                                 985,000            
      proceeds from sale of marketable securities
    		13,669,000                                             0 0 0 3,999,000             
      net cash from investing activities:
    		-24,670,000  -93,245,000 -65,704,000 -64,569,000  -22,724,000 -7,504,000 -5,884,000  -6,932,000 -6,791,000 -4,993,000  -9,298,000 -8,628,000 141,695,000  -4,430,000 -19,013,000 -3,712,000  -2,403,000                                       
      financing activities:
    		                                                             
      proceeds from issuance of common stock
    		3,527,000 240,000 2,444,000 493,000 4,373,000 789,000 2,733,000 3,286,000 2,805,000 1,626,000 4,923,000 1,386,000 6,847,000 1,016,000 6,482,000 3,897,000 5,652,000 10,180,000 9,981,000 2,200,000 3,065,000 3,754,000 2,723,000 544,000 1,554,000  1,332,000 224,000 596,000  2,127,000 537,000 1,839,000  1,346,000                498,000           
      payments on finance lease obligation
    		-91,000 -67,000 -65,000 -66,000 -62,000 -158,000 -125,000 -116,000 -112,000 -109,000 -105,000 -119,000 -38,000                                                 
      payments of tax withholdings related to vesting of stock-based awards
    		-6,815,000 -1,136,000 -614,000 -1,467,000 -33,929,000                                                         
      principal payments of acquisition contingent consideration
    		-29,000  -10,000                                                           
      net cash from financing activities:
    		-3,408,000  1,756,000 -144,321,000 -29,648,000  -43,201,000 -87,724,000 705,000  -5,957,000 -62,147,000 -14,679,000  2,476,000 -105,154,000 -111,796,000  9,890,000 2,126,000 2,121,000  2,546,000                                       
      effect of exchange rates on cash
    		-109,000  -347,000 221,000 -129,000  428,000 50,000 -6,000  -81,000 20,000 18,000  175,000 -3,000 13,000  9,000 9,000 2,000  3,000 2,000 -12,000  0 -12,000 -9,000  -29,000                               
      net increase in cash and cash equivalents
    		472,785,000 224,304,000 -14,777,000 -387,828,000 491,111,000 412,394,000 4,958,000 -36,181,000 55,995,000 23,861,000 360,000 -28,384,000 13,243,000 5,001,000 19,000 -63,137,000 65,726,000  -2,054,000 -22,446,000 27,986,000   2,120,000 -38,024,000 8,911,000 -22,175,000 -24,694,000 28,534,000 183,530,000 -710,000 -7,085,000 16,772,000   -22,426,000 29,519,000 -2,986,000 -2,037,000 -1,676,000 -39,777,000 10,287,000 -14,251,000 6,358,000 52,150,000 -441,000    28,655,000 10,915,000 -2,087,000 2,355,000   -742 4,873    7,571 
      cash and cash equivalents, beginning of period
    		802,751,000 0 0 0 489,941,000 0 0 0 52,775,000 0 0 0 43,695,000 0 0 0 36,086,000 0 0 0 169,508,000 0 0 0 191,471,000 0 0 0 200,895,000 0 0 0 8,388,000 0 0 0 14,856,000  0 0 61,332,000  0 0 6,788,000  0 0 89,003,000  0 0 36,625,000  0 0 34,930  0 0 36,322 
      cash and cash equivalents, end of period
    		1,275,536,000  -14,777,000 -387,828,000 981,052,000  4,958,000 -36,181,000 108,770,000  360,000 -28,384,000 56,938,000  19,000 -63,137,000 101,812,000  -2,054,000 -22,446,000 197,494,000  -2,204,000 2,120,000 153,447,000  -22,175,000 -24,694,000 229,429,000  -710,000 -7,085,000 25,160,000  -11,701,000 -22,426,000 44,375,000  -2,037,000 -1,676,000 21,555,000  -14,251,000 6,358,000 58,938,000  -7,602,000 -5,432,000 20,263,000  10,915,000 -2,087,000 38,980,000  -8,467 -742 39,803  -2,750 -16,815 43,893 
      supplemental disclosures of non-cash investing and financing transactions:
    		                                                             
      purchase of property, equipment and intangibles by incurring current liabilities
    		13,714,000  -23,483,000 23,880,000 7,284,000  1,361,000                                                       
      capital expenditures to be reimbursed under a government contract
    		   997,000 12,622,000                                                         
      reduction of other current liabilities upon issuance of restricted share units
    		2,850,000  0 0 2,001,000  0      1,970,000                408,000  0 0 663,000  0 9,000 447,000                         
      operating activities
    		                                                             
      impairment loss
    		         337,000                    0                                
      amortization of debt discount and deferred issuance costs
    		 100,000 101,000 101,000 101,000 156,000 182,000 216,000 217,000 215,000 216,000 549,000 602,000 597,000 641,000 1,043,000 1,671,000 1,893,000 1,388,000 1,376,000 1,365,000 1,625,000 1,412,000 1,425,000 1,429,000 1,432,000 1,422,000 1,411,000 1,399,000                                 
      change in fair value of acquisition contingencies
    		 116,000 0   557,000 0   841,000 0   369,000 0       104,000        -952,000 0 0 42,000                             
      change in fair value of derivative liabilities - convertible notes
    		                                                             
      payment of accreted interest on contingent and deferred consideration
    		 0 0                                                           
      loss on extinguishment of debt
    		     0    0 0    1,297,000 2,398,000 4,567,000                                             
      net cash from operating activities
    		                        -7,597,000 16,057,000 -3,010,000 -8,504,000 31,766,000 18,208,000 186,000 -4,865,000 22,157,000 1,464,000 -5,098,000 -5,129,000 34,445,000 13,748,000 1,619,000 1,480,000 2,786,000 13,111,000 142,000 8,093,000 25,636,000 3,097,000 667,000 -36,000 -14,021,000 45,089,000 15,864,000 2,415,000 16,083,000    5,776    7,810 
      capex
    		                        0 -4,965,000 -4,655,000 -4,481,000 -2,867,000 -2,657,000 -1,873,000 -2,652,000 -3,967,000 -3,879,000 -5,194,000 -8,928,000 -2,820,000 -5,318,000 -2,918,000 -2,927,000 -1,058,000 -201,000 -1,348,000 -1,518,000 -1,438,000 -2,172,000 -2,980,000 0 -978,000 -3,670,000 -1,591,000 0 0    0    0 
      free cash flows
    		                        -7,597,000 11,092,000 -7,665,000 -12,985,000 28,899,000 15,551,000 -1,687,000 -7,517,000 18,190,000 -2,415,000 -10,292,000 -14,057,000 31,625,000 8,430,000 -1,299,000 -1,447,000 1,728,000 12,910,000 -1,206,000 6,575,000 24,198,000 925,000 -2,313,000 -36,000 -14,999,000 41,419,000 14,273,000 2,415,000 16,083,000    5,776    7,810 
      investing activities
    		                                                             
      net cash from investing activities
    		                        -7,095,000 -5,029,000 -4,655,000 -4,481,000 -2,867,000 -2,657,000 -1,873,000 -2,652,000 -4,059,000 -4,175,000 -7,720,000 -18,298,000 -3,742,000 -5,453,000 -4,112,000 -3,164,000 -15,871,000 -3,166,000 -14,637,000 -1,501,000 -1,483,000 -3,136,000 -4,759,000 -1,153,000 -125,491,000 -2,954,000 -6,628,000           
      financing activities
    		                                                             
      payments on revolving credit facility
    		         -8,188,000 -10,000,000 -15,000,000 -20,000,000 -30,000,000 0 0 -10,000,000                                             
      repurchases of common stock
    		 0 0   -657,000 -2,384,000 -42,894,000 -1,954,000 -8,828,000 -29,000 -395,000 -1,476,000 -554,000 -183,000 -375,000 -3,232,000 0 -53,000 -51,000 -437,000 -72,000 -17,000 0 -20,079,000 -3,317,000 -15,484,000 -11,796,000 -337,000 0 -5,000 0 -1,951,000 -1,166,000 -133,000 -297,000 -561,000    -3,387,000                     
      payments on acquisition contingent consideration
    		             -9,000 -3,277,000                                               
      payments of deferred consideration
    		     0 0   0 0   0                                                
      payment on convertible note and derivative liability
    		                                                             
      transaction costs related to debt exchange
    		         0    0   -1,357,000                                             
      net cash from financing activities
    		                        -23,320,000 -2,121,000 -14,510,000 -11,697,000 -356,000 167,951,000 1,006,000 429,000 -1,326,000 856,000 1,117,000 1,001,000 -1,184,000 -11,281,000 456,000 8,000 -26,692,000 342,000 244,000 -234,000 27,997,000 -402,000 -3,510,000 -4,243,000 70,772,000 -13,480,000 1,679,000      164 5,123,470 1,922 1,383 225 
      effect of exchange rate changes on cash
    		                                                             
      cash and cash equivalents, at end of period
    		                                                             
      change in fair value of derivative liabilities - convertible senior notes
    		     0 0                                                       
      principal payments of deferred consideration
    		  1,000                                                           
      payment on convertible senior note and derivative liability
    		     -30,000                                                        
      extinguishment of convertible senior notes through issuance of stock
    		                                                             
      acquisitions of property, equipment and intangibles
    		   -75,245,000 -78,291,000 -28,815,000 -22,724,000 -7,504,000 -5,884,000     -8,814,000 -9,298,000 -8,628,000 -4,949,000 -4,743,000 -4,697,000 -4,358,000 -3,712,000 -4,049,000 -2,436,000 -3,423,000 -2,001,000                                     
      initial measurement of derivative liabilities – convertible senior notes
    		                                                             
      payments of acquisition contingent consideration
    		    -30,000  -9,000 -6,000,000 -34,000  -13,000 -4,019,000 -12,000                                                 
      amortization of inventory step-up to fair value
    		             0 0 0 3,650,000                                             
      proceeds from sale of summers ridge property
    		             0 0 0 146,644,000                                             
      payments of debt issuance costs
    		                         0 0 0 -365,000                                 
      payments of term loan
    		             0                                                
      extinguishment of convertible senior notes through issuance of common stock
    		      460,000                                                       
      acquisitions of property, equipment
    		                                                             
      acquisition of other businesses, net of cash acquired
    		                                                             
      acquisition of triage and bnp businesses
    		                                                             
      proceeds from issuance of term loan
    		                                                             
      proceeds from issuance of revolving credit facility
    		                                                             
      payment of debt issuance costs
    		                                                             
      acquisitions of property and equipment
    		           -6,791,000 -4,993,000             -4,965,000 -4,655,000 -4,481,000 -2,867,000 -2,657,000 -1,873,000 -2,652,000 -3,967,000 -3,879,000 -5,194,000 -8,928,000 -2,820,000 -5,318,000 -2,918,000 -2,927,000 -1,058,000 -201,000 -1,348,000 -1,518,000 -1,438,000 -2,172,000 -2,980,000               
      purchase of property and equipment by incurring current liabilities
    		            1,728,000                                                 
      non-cash financing activities:
    		                                                             
      gain on extinguishment of debt
    		                                                             
      payments on lease obligation
    		             -37,000 -33,000 -31,000 -29,000 -28,000 -26,000 -23,000 -21,000 -107,000 -148,000 -144,000 -141,000 -134,000 -129,000 -125,000 -121,000 -115,000 -113,000 -108,000 -105,000 -100,000 -96,000 -93,000 -91,000 -87,000 -82,000 -82,000 -78,000 -73,000 -71,000 -69,000 -67,000 -52,000 -53,000 -52,000 -48,000             
      repurchases of convertible senior notes
    		                     0 0 0 -4,459,000                                     
      income taxes receivable
    		              -5,511,000 -4,388,000 3,097,000  -257,000 -2,929,000 2,063,000  -311,000 -56,000 119,000  632,000 -770,000 372,000  1,307,000                               
      principal amount of term loan exchanged for revolving credit facility
    		                                                             
      payments on deferred consideration
    		                                                             
      payments on term loan
    		               -60,000,000 -101,813,000                                             
      payments of debt transaction costs
    		                                                             
      payments on acquisition contingencies
    		                -1,017,000 1,000 -12,000 0 -486,000 0 -12,000 0 -195,000 0 0 0 -129,000 0 -1,003,000 0 -1,109,000                             
      gain on extinguishment of convertible senior notes
    		                     0 0 0 -421,000                                     
      restricted cash
    		                     0 0 0 63,000 1,747,000 3,051,000 -1,396,000 -338,000 2,920,000                                
      deferred grant revenue
    		                     0 -961,000 -951,000 -1,746,000 -1,859,000 -777,000 1,176,000 -1,212,000 -1,583,000                                
      payment for acquisition holdback
    		                         0                                    
      net decrease in cash and cash equivalents
    		                                               -5,432,000 -68,740,000             
      acquisition of businesses, net of cash acquired
    		                  267,000                                           
      acquisition of immutopics, net of cash acquired
    		                     0 33,000 0 -5,094,000                                     
      excess tax benefit from share-based compensation
    		                                 -1,409,000 0 0 -937,000             -29,000            
      proceeds from issuance of convertible senior notes
    		                                                             
      net income:
    		                        -3,446,000                                     
      acquisition of biohelix, net of cash acquired
    		                                  -34,000                           
      acquisition of andiatec
    		                                                             
      acquisition of intangibles
    		                             0 0 0 -92,000  -221,000 -220,000 -922,000    -14,928,000                     
      proceeds from issuance of common stock, net of cancellations
    		                                    3,531,000        58,558,000 95,000 178,000 80,000 798,000             
      payments on line of credit
    		                                 0 0 0 -5,000,000 -14,000,000 0 0 -23,000,000 0 0                   
      supplemental disclosures of cash flow information:
    		                                                             
      cash paid for interest
    		                          286,000 3,208,000 250,000  258,000 292,000 175,000  165,000 195,000 204,000                         
      cash paid for income taxes
    		                          1,282,000 517,000 121,000  24,000 392,000 51,000  0 956,000 944,000                         
      non-cash investing activities:
    		                                                             
      purchase of capital equipment by incurring current liabilities
    		                          311,000 958,000 164,000  -183,000 -308,000 760,000 -595,000 -240,000 -497,000 1,504,000 531,000 255,000 15,000 285,000 3,000 1,000 60,000 96,000 32,000 -67,000               
      reduction of other current liabilities upon issuance of restricted stock units
    		                          0                                   
      increase of other current liabilities for purchase of common stock
    		                                                             
      loss on disposal of assets
    		                                      13,000                       
      purchase of business
    		                                                             
      proceeds from sale of fixed assets
    		                                     7,000 0                       
      payment of note payable to state agency
    		                                        -1,498,000                     
      other
    		                                     0     -138,000 -83,000 -208,000 -693,000 -635,000 234,000 -302,000             
      payment on line of credit
    		                                                             
      impairment of intangible assets
    		                                                             
      change in fair value of acquisition contingency
    		                                                             
      accrued royalties
    		                                 40,000 -24,000 -45,000 36,000 23,000 -162,000 -3,000 17,000 -140,000 -1,323,000 -2,736,000 2,201,000 362,000 250,000 -690,000 -3,437,000 861,000 2,657,000           
      accrued income taxes payable
    		                                 -88,000 368,000 -6,331,000 2,528,000 135,000      -100,000 -8,000 -758,000 758,000 0 -6,151,000             
      aquisition of biohelix, net of cash acquired
    		                                                             
      aquisition of andiatec
    		                                                             
      aquisition of intangibles
    		                                                             
      payment on acquisition contingency
    		                                                             
      supplemental disclosures of cash flow information
    		                                                             
      cash paid during the period for interest
    		                                      286,000 292,000 407,000  485,000 499,000 655,000  644,000 612,000 399,000  148,000 193,000 181,000  188 191 194  201 203 207 
      cash paid during the period for income taxes
    		                                          80,000    452,000 0 6,500,000  0 6,000 182,000         
      non-cash investing activities
    		                                                             
      purchase of licensed technology by incurring current liabilities
    		                                         -1,734,000                    
      lease incentive for tenant improvements
    		                                                             
      non-cash financing activities
    		                                                             
      decrease of accrued payroll and related expenses upon issuance of common stock
    		                                                             
      decrease of other non-current assets upon issuance of common stock
    		                                                             
      proceeds from the sale of fixed assets
    		                                        115,000                     
      increase of other non-current assets upon issuance of common stock
    		                                                             
      income tax payable
    		                                                             
      income tax receivable
    		                                     136,000 0 0 31,000 -90,000 420,000 7,840,000 7,000 -2,890,000 -2,146,000               
      impairment of long-lived and intangible assets
    		                                                             
      loss on disposal of property, plant and equipment
    		                                                    6,000         
      purchase of business, net of cash acquired of - for 2012 and 3,150 for 2010
    		                                                             
      borrowing from line of credit
    		                                             0 0 0 75,000,000             
      payments on note payable to state agency
    		                                     0 0                       
      cash and cash equivalents at beginning of year
    		                                                             
      cash and cash equivalents at end of year
    		                                                             
      reduction of other non-current assets upon issuance of common stock
    		                                                             
      prepaid expenses and other current assets
    		                                      -1,847,000    -694,000 194,000 -477,000 933,000 -353,000 928,000 -818,000 -475,000 -193,000           
      acquisitions of intangibles
    		                                      -194,000                       
      purchases of common stock
    		                                      -20,000   -1,000 0 -339,000 -286,000  0               
      issuance of common stock, net of cancellations
    		                                      1,599,000 90,000 1,271,000  453,000                   
      acquisition of other non-current assets upon issuance of common stock
    		                                                             
      purchase of business, net of cash acquired of 3,150
    		                                                             
      gain on sale of assets
    		                                          6,000   7,000 0               
      payment for licensed technology
    		                                                             
      other assets
    		                                          -72,000 17,000 -45,000 16,000 290,000 86,000 -311,000 -19,000 -53,000   307,868 26 52 54     
      purchase of business, net of cash acquired of 3.1 million
    		                                             20,000 -69,000               
      purchase of business, net of cash acquired of 3.0 million
    		                                                -128,201,000             
      payments on borrowing from line of credit
    		                                            -30,000,000 0                
      purchase of common stock
    		                                                -4,676,000 -13,970,000 0           
      fees paid to establish line of credit
    		                                                             
      purchase of license agreements by incurring current liabilities
    		                                                             
      deferred tax asset
    		                                              6,212,000 -5,658,000 -1,501,000 429,000 3,584,000           
      acquisition of property and equipment
    		                                                -978,000 -3,670,000 -1,591,000           
      payments on capital lease obligation
    		                                                  -219,000           
      depreciation and amortization
    		                                                   2,437,000 2,618,000 9,102,854 1,924 2,210 2,012     
      deferred income taxes
    		                                                   -1,204,000 3,145,000         
      other accrued liabilities
    		                                                    216,000         
      acquisition of property, plant and equipment
    		                                                             
      payments to acquire common stock
    		                                                             
      proceeds from issuance of stock under stock plans
    		                                                   961,000 326,000  1,942 73 325     
      effect of exchange rate changes on cash and cash equivalents
    		                                                      3 15 4     
      net earnings
    		                                                     21,714,578 2,143       
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                                             
      (gain) loss on discontinued operations
    		                                                             
      foreign currency translation
    		                                                             
      change in deferred tax asset
    		                                                             
      excess tax benefit from share based compensation
    		                                                             
      deferred rent
    		                                                             
      deferred revenue
    		                                                             
      other current liabilities
    		                                                             
      net cash from continuing operations
    		                                                        5,776    7,871 
      net cash used by discontinued operations
    		                                                             
      acquisition of plant and equipment
    		                                                             
      net increase in intangible assets
    		                                                             
      payments on debt and obligations under capital leases
    		                                                             
      income from discontinued operations
    		                                                             
      earnings from continuing operations
    		                                                      2,143 -4,049 5,328     
      adjustments to reconcile net earnings to net cash from (used by) operating activities:
    		                                                             
      loss on disposal of property plant and equipment
    		                                                             
      net cash from (used by) continuing operations
    		                                                      -1,077    1,648   
      net cash from discontinued operations
    		                                                             
      net cash from (used by) operating activities
    		                                                      -1,077       
      acquisition of intangible assets
    		                                                             
      payments on capital lease obligations
    		                                                             
      payments to repurchase common stock
    		                                                             
      net cash from (used by) financing activities
    		                                                             
      accrued patent litigation
    		                                                             
      adjustments to reconcile earnings from continuing operations to net cash from operating activities:
    		                                                             
      compensation expense on stock awards
    		                                                             
      increase in intangible assets
    		                                                             
      payments on obligations under capital leases
    		                                                             
      net proceeds from issuance of common stock and warrants
    		                                                          2,424 1,528 368 
      net cash from (used by) discontinued operations
    		                                                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.